Home
>
Stock Market
>
>
Aurobindo Pharma Ltd

Aurobindo Pharma Ltd share price and stock overview

Q: What is the NSE symbol and BSE code for Aurobindo Pharma Ltd?

Aurobindo Pharma Ltd trades on NSE under the symbol AUROPHARMA and on BSE under code 524804. The ISIN is INE406A01037 and the face value is Rs 1.

Aurobindo Pharma Ltd (NSE: AUROPHARMA, BSE: 524804) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE406A01037 and a face value of Rs 1. As of 19 July 2026, it trades at Rs (1,533.40) with a market capitalisation of Rs 89097.87 crore. Figures are live and subject to change.

Aurobindo Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

NSE BSE

1,533.40 -15.00 (-0.97%) downArrowC

As on: 19-Jul-2026 , 11:35 AM

Market Cap(₹Cr) 89097.87

Book Value(₹Cr) 391.1437121

BSE Code : 524804 NSE Symbol : AUROPHARMA EPS(TTM) : 41.81 ISIN Demat : INE406A01037 P/E(TTM) : 36.69 Face Value(₹) : 1 Div & Yield % : 0.26

Today Market

Stock Performance

Today Market

Today's High

78,282.55

Todday's Low

77,308.00

Open at

77,370.77

Previous Close

77,186.87

Volumes

Avg Price

964.58

Historical Performance

News

10 Jul 26

Aurobindo Pharma announces incorporation of subsidiary in Indonesia

Aurobindo Pharma announced that PT Aurogen Pharma Indonesia, a wholly owned stepdown subsidiary of the Company, has incorporated a new wholly owned subsidiary company by the name of PT Auro Pharm Indonesia, in Indonesia.

02 Jul 26

Aurobindo Pharma completes transfer of its branded generic products biz to Auropharm

Aurobindo Pharma has completed the transfer of the Company's domestic branded generic pharmaceutical formulations products business, as a going concern to Auropharm with effect from 01 July 2026.

30 Jun 26

Aurobindo Pharma USA Inc. completes acquisition of Lannett

Aurobindo Pharma USA Inc., (APUSA), a wholly owned subsidiary of Aurobindo Pharma, announced the successful completion of its acquisition of Lannett Company, Inc.

29 Jun 26

Aurobindo Pharma's API unit clears USFDA inspection with two observations

The inspection, conducted between 22 June and 26 June 2026, covered the facility that manufactures active pharmaceutical ingredients (APIs) and pharmaceutical formulation intermediates.

Historical Prices

Share Price Chart

Historical Share Price

Date	Open Price (₹)	High Price(₹)	Low Price(₹)	Close Price(₹)	Total Volume	No of Trades	Net Turnover(₹)	NIFTY
17-07-26	1550.00	1550.00	1520.40	1533.40	518043	30084	794317920.90	24334.30
16-07-26	1550.20	1565.00	1542.60	1548.40	924372	71048	1435898023.50	24072.75
15-07-26	1553.70	1565.70	1546.00	1550.20	327039	15600	508192532.80	24078.50
14-07-26	1551.40	1572.00	1545.90	1552.80	525859	22227	820444905.80	24052.05
13-07-26	1564.90	1584.70	1541.00	1549.30	735761	28113	1144798805.50	24211.00
10-07-26	1576.10	1580.50	1544.30	1564.70	1154492	56875	1803620303.80	24206.90
09-07-26	1555.00	1602.80	1550.10	1587.40	803529	44839	1276162630.10	23962.80
08-07-26	1575.50	1611.40	1552.10	1557.40	1106058	57684	1750236060.10	23882.05
07-07-26	1600.00	1600.00	1575.30	1583.10	638542	41551	1013516831.10	24398.70
06-07-26	1622.50	1630.00	1586.00	1594.60	786004	47635	1262061156.40	24430.35

12 3 ...

Fundamentals

Company Valuation

Market Cap (₹cr)

89097.87

PE Ratio

36.69

PB Ratio

3.92

Dividend Yield

0.26

ROE

8.68

ROCE

10.82

Book Value (₹)

391.1437121

Face Value (₹)

Share Holding Pattern

Category of Shareholder	No of Shares	% Share Holdings	Demat Shares	Share Holders

Promoter & Group

Foreign

Foreign (Promoter & Group) - Bodies Corporate	0	0.00	0	0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign)	17690341	3.07	17690341	1
Foreign Promoter(Institutional)	0	0.00	0	0
Promoter Others	0	0.00	0	0

Sub Total

17690341

3.07

17690341

Indian

Bodies Corporate-Indian (Promoter & Group)	210859525	36.65	210859525	4
Government(Central / State)-Indian (Promoter & Group)	0	0.00	0	0
Directors & their Relatives-Indian (Promoter & Group)	0	0.00	0	0
Financial Institutions / Banks-Indian (Promoter & Group)	0	0.00	0	0
Individuals / Hindu Undivided Family-Indian (Promoter & Group)	69972860	12.16	69972860	9
Partnership Firms-Indian (Promoter & Group)	0	0.00	0	0
Persons Acting in Concert	0	0.00	0	0
Trusts	0	0.00	0	0
Others	0	0.00	0	0

Sub Total

280832385

48.81

280832385

Total ShareHolding for Promoter & Group

298522726

51.88

298522726

Publice Share Holding

Institution

Government(Central / State)	0	0.00	0	0
Clearing Members	0	0.00	0	0
Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
Financial Institutions / Banks	210	0.00	210	1
Foreign Bank	0	0.00	0	0
Foreign Bodies Corporate/OCBs/FBC	0	0.00	0	0
Foreign Collaborators	0	0.00	0	0
Foreign Institutional Investors	94230349	16.38	94230349	674
Foreign Venture Capital Investors	0	0.00	0	0
Foreign Institution Other	0	0.00	0	0
Insurance Companies	28711115	4.99	28711115	24
Mutual Funds / UTI	96131215	16.71	96131215	42
Individuals (Non-Resident / Foreign)	0	0.00	0	0
NSDL Intransit	0	0.00	0	0
Others	19575841	3.40	19575841	40
Trusts	0	0.00	0	0
Venture Capital Funds	0	0.00	0	0

Sub total

238648730

41.48

238648730

781

Non Institution

Bodies Corporate	2847086	0.49	2845976	1820
Clearing Members	422236	0.07	422236	6
Directors & their Relatives	4010	0.00	4010	2
Employees	0	0.00	0	0
Escrow Account	0	0.00	0	0
Foreign Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
NRIs/Foreign Individuals/Foreign Nationals	2161183	0.38	2161183	8173
Foreign Non Institution Other	410	0.00	410	1
Hindu Undivided Families	827397	0.14	827397	3730
Indian Public	0	0.00	0	0
Individuals holding nominal share capital in excess of Rs. 1 lakh	1883878	0.33	1883878	5
Individuals holding nominal share capital up to Rs. 1 lakh	28963904	5.03	28390504	224519
Market Maker	0	0.00	0	0
NSDL Transit	0	0.00	0	0
Shares in transit	0	0.00	0	0
Societies	0	0.00	0	0
Trust & Foundation	155745	0.03	155745	17
Others	939810	0.16	939810	4

Sub Total

38206439

6.64

37631929

238278

Total Public Shareholding

276855169

48.12

276280659

239059

Total of Promoter & Public ShareHolding

575377895

100.00

574803385

239073

Shares held by Custodians and against which Depository Receipts have been issued

ADR	0	0.00	0	0
GDR	0	0.00	0	0
Other Custodians	0	0.00	0	0

Total Shares held by Custodians and against which Depository Receipts have been issued

0.00

Grand Total

575377895

100.00

574803385

239073

Financials (₹ in cr)

Consolidated Standalone

Year End	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Net Sales	31,723.73	29,001.87	24,855.38	23,455.49	24,774.62
OPM (%)	15.97	15.76	10.51	14.92	18.28
OP	5,066.29	4,571.85	2,612.50	3,500.71	4,529.01
Other Income	621.85	557.38	290.59	320.35	380.85
PBIDT	7,172.95	6,191.36	3,997.56	4,547.90	8,473.47
INTEREST	457.24	289.71	140.48	48.64	74.49
PBDT	6,715.71	5,901.65	3,857.08	4,499.26	8,398.98
PBT	5,066.29	4,188.13	2,612.50	3,244.77	10,158.17
EO	0.00	-191.86	0.00	-127.97	2,814.58
PBT after EO	5,066.29	4,379.99	2,612.50	3,372.74	7,343.59
TAXES	1,582.72	1,211.02	684.85	725.63	2,009.77
PAT	3,485.88	3,172.97	1,927.50	2,648.15	5,334.84
EPS	59.81	54.16	32.90	45.20	91.05
Raw Material	33.84	37.16	38.83	31.43	33.57
Power and Fuel	3.19	2.85	3.39	2.67	2.38
Employee Cost	14.11	13.53	14.17	14.71	14.27
Other Manufacturing Expenses	1.38	1.39	1.58	1.79	1.72
Selling and Administration Expenses	14.50	13.70	14.91	14.21	14.69
Miscellaneous Expenses	2.28	2.38	3.00	1.96	2.69
Revenue (Growth %)	9.39	16.68	5.97	-5.32	7.26
PBIDT (Growth %)	15.85	54.88	-12.10	-46.33	68.97
PAT (Growth %)	9.86	64.62	-27.21	-50.36	87.51
PBIDT (Margin %)	22.61	21.35	16.08	19.39	34.20
PAT (Margin %)	10.99	10.94	7.75	11.29	21.53

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Share Capital	58.08	58.59	58.59	58.59	58.59	58.59
Reserves Total	20476.03	19664.23	17975.44	17058.75	15866.02	12993.91
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	20534.11	19722.82	18034.03	17117.34	15924.61	13052.50
Secured Loans	1842.41	1431.99	1922.78	288.75	841.50	1314.36
Unsecured Loans	2804.19	1428.75	2280.38	1606.14	3186.02	2427.10
Total Debt	4646.60	2860.74	4203.16	1894.89	4027.52	3741.46
Other Liabilities	53.30	46.00	87.31	5.03	0.00	42.68
Total Liabilities	25234.01	22629.56	22324.50	19017.26	19952.13	16836.64
APPLICATION OF FUNDS :
Gross Block	4230.61	4043.49	6214.71	5724.90	6820.35	6180.91
Less : Accumulated Depreciation	1893.81	1624.36	2527.21	2139.07	2348.28	1763.11
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	2336.80	2419.13	3687.50	3585.83	4472.07	4417.80
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	87.53	132.68	239.09	225.15	734.89	814.85
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	15209.57	13393.44	8105.37	6584.36	5009.93	2527.41
Current Assets, Loans & Advances
Inventories	2359.28	2367.60	4125.26	3356.18	4841.38	4359.57
Sundry Debtors	4195.05	3776.59	4560.26	3973.24	5928.01	5785.00
Cash and Bank Balance	298.36	94.34	373.41	50.78	386.18	86.16
Loans and Advances	836.70	1000.59	906.05	2454.90	1093.25	1057.55
Total Current Assets	7689.39	7239.12	9964.98	9835.10	12248.82	11288.28
Less : Current Liabilities and Provisions
Current Liabilities	2092.61	2285.86	2396.31	2243.30	2553.47	2526.66
Provisions	85.01	119.65	122.09	103.36	250.01	115.27
Total Current Liabilities & Provisions	2177.62	2405.51	2518.40	2346.66	2803.48	2641.93
Net Current Assets	5511.77	4833.61	7446.58	7488.44	9445.34	8646.35
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	51.87	47.45	55.24	43.82	68.61	411.92
Deferred Tax Liability	153.30	166.36	271.15	280.85	501.99	496.96
Net Deferred Tax	-101.43	-118.91	-215.91	-237.03	-433.38	-85.04
Other Assets	2189.77	1969.61	3061.87	1370.51	723.28	515.27
Total Assets	25234.01	22629.56	22324.50	19017.26	19952.13	16836.64
Contingent Liabilities	220.81	206.15	534.26	152.93	887.66	2006.56

Cash Flow (₹ in cr)

Yearly Cash Flow	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Financing Activities	-27.94	-2,447.54	1,719.48	-1,837.03	616.31
Investing Activities	-2,650.24	-1,614.54	-3,229.65	-151.58	-2,050.16
Net Cash Flow	316.23	-335.37	306.00	-273.81	211.94
Operating Activities	2,994.41	3,726.71	1,816.17	1,714.80	1,645.79

Peers

Balance Sheet Financial Ratios Profit & Loss

No Data Available!!!

Corporate Actions

Bonus Dividends Splits

Date	Corporate Action	Information
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer

KNR

Kambam Nityananda Reddy

Vice Chairman & Managing Director

Executive

MRK

M R Kumar

Chairman & Independent Director

Executive

Functional Directors

MMM

M Madan Mohan Reddy

Whole-time Director

WTD

PVR

P V Ramprasad Reddy

Non Executive Director

Exec.

PSC

P Sarath Chandra Reddy

Non Executive Director

Exec.

Satakarni Makkapati

Non Executive Director

Exec.

PKS

Punita Kumar Sinha

Additional Director

Dir.

Independent Directors

GPV

Girish Paman Vanvari

Independent Director

Ind.

Santanu Mukherjee

Independent Director

Ind.

Other Officials

BAR

B Adi Reddy

Company Sec. & Compli. Officer

Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Aurobindo Pharma Ltd? −

Aurobindo Pharma Ltd trades on NSE under AUROPHARMA and on BSE under code 524804. The ISIN is INE406A01037 and the face value is Rs 1.

What is the share price of Aurobindo Pharma Ltd today? +

As of 19 July 2026, Aurobindo Pharma Ltd trades at Rs 1,533.40, a change of -15.00 (-0.97%) on the day. Prices are live and subject to change.

What is the market capitalisation of Aurobindo Pharma Ltd? +

As of 19 July 2026, Aurobindo Pharma Ltd has a market cap of about Rs 89097.87 crore. This figure is live and moves with the share price.

Is Aurobindo Pharma Ltd profitable? +

In March 2025, Aurobindo Pharma Ltd reported a profit after tax of Rs 3,485.88 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Aurobindo Pharma Ltd? +

: As of 19 July 2026, the PE (TTM) for Aurobindo Pharma Ltd is 36.69 and the price-to-book ratio is 3.92. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Aurobindo Pharma Ltd pay a dividend? +

As of 19 July 2026, the dividend yield for Aurobindo Pharma Ltd is 0.26%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Aurobindo Pharma Ltd? +

As of the latest disclosed pattern, promoters hold 51.88% of Aurobindo Pharma Ltd. Public shareholding is 48.12%, including mutual funds at 16.71% and foreign institutional investors at 16.38%.

What were the latest annual financials of Aurobindo Pharma Ltd? +

In March 2025, Aurobindo Pharma Ltd reported net sales of Rs 31,723.73 crore, revenue growth of 9.39%, and earnings per share of Rs 59.81.

Aurobindo Pharma Ltd share price and stock overview

Stock Performance

Today Market

Historical Performance

News

Historical Prices

Share Price Chart

Historical Share Price

Fundamentals

Company Valuation

Share Holding Pattern

Financials (₹ in cr)

Balance Sheet (₹ in cr)

Cash Flow (₹ in cr)

Peers

Corporate Actions

Board of Directors

Frequently Asked Questions

What is the NSE symbol and BSE code for Aurobindo Pharma Ltd? −

What is the share price of Aurobindo Pharma Ltd today? +

What is the market capitalisation of Aurobindo Pharma Ltd? +

Is Aurobindo Pharma Ltd profitable? +

What is the PE ratio of Aurobindo Pharma Ltd? +

Does Aurobindo Pharma Ltd pay a dividend? +

What is the shareholding pattern of Aurobindo Pharma Ltd? +

What were the latest annual financials of Aurobindo Pharma Ltd? +

Invest with clarity